Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Multicentric, Transversal, Descriptive, Epidemiological Study on the Management of Asthma in Asthmatic Middle East Adult Population (ESMAA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02153411
Recruitment Status : Completed
First Posted : June 3, 2014
Last Update Posted : November 8, 2016
Sponsor:
Information provided by (Responsible Party):
AstraZeneca

Brief Summary:
Descriptive study on the management of asthma in asthmatic Middle East adult population : Algeria,Egypt, Irak,Iran, Jordan, Koweit, Lebanon, Qatar,Saudi,Tunisia, UAE

Condition or disease
Asthma

Detailed Description:
Multicentric, transversal, descriptive, epidemiological study, conducted in a random sample of general practitioner and medical specialist (Pulmonologist and/or allergologist) in the public and the private sector.

Layout table for study information
Study Type : Observational
Actual Enrollment : 7294 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Evaluation of aSthma Management in Middle EAst Adult Population
Study Start Date : June 2014
Actual Primary Completion Date : December 2015
Actual Study Completion Date : December 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Asthma

Group/Cohort
8645 asthmatic patients
Men and women, 18 years of age and older. Asthmatic since at least one year before inclusion. Patient's informed consent obtained.



Primary Outcome Measures :
  1. Asthma control [ Time Frame: Up to 1 year ]
    Daytime symptoms Limitation of activities Nocturnal symptoms / awakening Need for reliever /rescue treatment Lung function (PEF or FEV)


Secondary Outcome Measures :
  1. general and sociodemographic patient's characteristics [ Time Frame: up to 1 year ]
    sex, age, BMI, educational level, occupation, comorbidities, smoking status, and social security coverage.

  2. Identify predictive factors of asthma control, [ Time Frame: UP to 1 year ]
    such as age, sex, BMI, smoking status, adherence to treatment, asthma history, comorbidity.

  3. asthma control level [ Time Frame: Up to 4 weeks ]
    Asthma control test questionnaire : activities at work,breathless,asthma symptoms (wheezing, coughing, chest tightness, shortness of breath;use of rescue inhaler or taken a nebulizer treatment ,asthma assessment



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 130 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Asthmatic since at least one year before inclusion. Patient's informed consent obtained.
Criteria

Inclusion Criteria:

Men and women, 18 years of age and older. Asthmatic since at least one year before inclusion. Patient's informed consent obtained.

Exclusion Criteria:

  • Patient concurrently participating to another study. Patient with concomitant pulmonary disease. Patient with psychiatric disorders. Patient consulting for an asthma attack

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02153411


Locations
Show Show 98 study locations
Sponsors and Collaborators
AstraZeneca

Additional Information:
Layout table for additonal information
Responsible Party: AstraZeneca
ClinicalTrials.gov Identifier: NCT02153411    
Other Study ID Numbers: NIS-RME-XXX-2014/1
NIS-RME-XXX-2014/1 ( Registry Identifier: NIS Registry )
First Posted: June 3, 2014    Key Record Dates
Last Update Posted: November 8, 2016
Last Verified: November 2016
Keywords provided by AstraZeneca:
Asthma control
Additional relevant MeSH terms:
Layout table for MeSH terms
Asthma
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases